• Dr. Reddy's received an FDA Form 483 with three observations at its FTO-9 manufacturing facility in Visakhapatnam, Andhra Pradesh.
• The pre-approval inspection ran from October 8 to October 9, 2026.
• The company will address the observations within the stipulated timeline.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dr. Reddy's Laboratories Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001575872-26-000700), on October 14, 2026, and is solely responsible for the information contained therein.